Io Biotech Inc (IOBT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -17,044 | -71,458 | -51,387 | -35,699 | -17,204 |
| Depreciation Amortization | 47 | 104 | 32 | 19 | N/A |
| Income taxes - deferred | N/A | 87 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 256 | 77 | -1,759 | 613 | -1,841 |
| Other Working Capital | 550 | 4,192 | -1,937 | -1,670 | -5,500 |
| Other Operating Activity | 1,501 | 7,269 | 7,848 | 2,882 | 3,701 |
| Operating Cash Flow | $-14,690 | $-59,729 | $-47,203 | $-33,855 | $-20,844 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -148 | -690 | -341 | -223 | -116 |
| Investing Cash Flow | $-148 | $-690 | $-341 | $-223 | $-116 |
| Cash Flows From Financing Activities | |||||
| Financing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Exchange Rate Effect | 775 | -8,522 | -12,819 | -7,331 | -2,667 |
| Beginning Cash Position | 142,858 | 211,799 | 211,799 | 211,799 | 211,799 |
| End Cash Position | 128,795 | 142,858 | 151,436 | 170,390 | 188,172 |
| Net Cash Flow | $-14,063 | $-68,941 | $-60,363 | $-41,409 | $-23,627 |
| Free Cash Flow | |||||
| Operating Cash Flow | -14,690 | -59,729 | -47,203 | -33,855 | -20,844 |
| Capital Expenditure | -148 | -690 | -341 | -223 | -116 |
| Free Cash Flow | -14,838 | -60,419 | -47,544 | -34,078 | -20,960 |